Substituted dipeptides as growth hormone secretagogues

Details for Australian Patent Application No. 2002211219 (hide)

Owner Eli Lilly and Company

Inventors Ruehter, Gerd; Jungheim, Louis Nickolaus; Dodge, Jeffrey Alan; Thrasher, Kenneth Jeff; Muehl, Brian Stephen; Evers, Britta

Agent Spruson & Ferguson

Pub. Number AU-B-2002211219

PCT Pub. Number WO02/32888

Priority 60240456 13.10.00 US

Filing date 9 October 2001

Wipo publication date 29 April 2002

Acceptance publication date 14 September 2006

International Classifications

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

14 September 2006 Application Accepted

  Published as AU-B-2002211219

18 January 2007 Standard Patent Sealed

8 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002211220

2002211218